Boston Scientific has inked a deal of up to $270m for embolic protection system developer Claret Medical, marking its second acquisition in the space of two weeks.
Boston Scientific Corp. is in the lead as the most prolific shopper this year so far, having scored two more acquisition deals this month.
The medtech multinational's July 20 agreement to acquire Claret Medical Inc., maker of the Sentinel cerebral embolic protection system, is its fifth M&A deal
States and international regulatory bodies may increase their US enforcement role following federal staff cuts, Hyman Phelps & McNamara attorneys said in a recent webinar. The attorneys also expect False Claims Act enforcement and public health to remain key areas of focus at the federal level.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.
